MX2022005084A - Formas sólidas de un modulador del receptor s1p a. - Google Patents

Formas sólidas de un modulador del receptor s1p a.

Info

Publication number
MX2022005084A
MX2022005084A MX2022005084A MX2022005084A MX2022005084A MX 2022005084 A MX2022005084 A MX 2022005084A MX 2022005084 A MX2022005084 A MX 2022005084A MX 2022005084 A MX2022005084 A MX 2022005084A MX 2022005084 A MX2022005084 A MX 2022005084A
Authority
MX
Mexico
Prior art keywords
solid forms
receptor modulator
sip
diseases
activity
Prior art date
Application number
MX2022005084A
Other languages
English (en)
Inventor
Lombaert Stéphane De
Rio Gancedo Susana Del
Sarno Ana Rosario Mollo
Michael A Christie
Edward L Ciolkowski
Joseph Stephen Harris
Lucy Kristina Mapp
Mateusz Bogumil Pitak
Scott L Childs
Original Assignee
Escape Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Escape Bio Inc filed Critical Escape Bio Inc
Publication of MX2022005084A publication Critical patent/MX2022005084A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

Esta solicitud se refiere a formas sólidas de un modulador del receptor de S1P de la fórmula a continuación, que son útiles en el tratamiento de enfermedades o trastornos asociados con la actividad de S1P, incluidos los trastornos del SNC. Compuesto 1.
MX2022005084A 2019-10-31 2020-10-30 Formas sólidas de un modulador del receptor s1p a. MX2022005084A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962928412P 2019-10-31 2019-10-31
PCT/US2020/058269 WO2021087299A1 (en) 2019-10-31 2020-10-30 Solid forms of an s1p-receptor modulator

Publications (1)

Publication Number Publication Date
MX2022005084A true MX2022005084A (es) 2022-05-26

Family

ID=73544378

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005084A MX2022005084A (es) 2019-10-31 2020-10-30 Formas sólidas de un modulador del receptor s1p a.

Country Status (12)

Country Link
US (2) US11535632B2 (es)
EP (1) EP4051683A1 (es)
JP (1) JP2022553802A (es)
KR (1) KR20220123634A (es)
CN (1) CN114728982A (es)
AU (1) AU2020373047A1 (es)
BR (1) BR112022008113A2 (es)
CA (1) CA3159378A1 (es)
IL (1) IL292547A (es)
MX (1) MX2022005084A (es)
TW (1) TW202132311A (es)
WO (1) WO2021087299A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI543984B (zh) 2010-07-09 2016-08-01 艾伯維公司 作為s1p調節劑的螺-哌啶衍生物
CN117007818B (zh) * 2023-08-04 2024-04-09 徐州医科大学科技园发展有限公司 S1pr1作为靶点在开发或制备用于预防慢性疼痛相关记忆损伤疾病的药物中的应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1069387A1 (ru) 1982-07-01 1985-11-30 Институт физико-органической химии и углехимии АН УССР Дигидрохлорид 5-/ @ -( @ -анизил)- @ -оксиэтил/ 2-(3,4-диметоксифенил)-1-метил-4,5,6,7-тетрагидроимидазо(4,5- @ )пиридина,обладающий спазмолитическим действием
GB2228432A (en) 1989-01-13 1990-08-29 Grayston Central Services Multi-role machine for heating and coating pipe welds.
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
JPH03206042A (ja) 1990-01-06 1991-09-09 Takeda Chem Ind Ltd 降圧剤
JP2681589B2 (ja) 1992-12-28 1997-11-26 日揮株式会社 配管溶接継手の熱処理方法
JPH072848A (ja) 1993-04-23 1995-01-06 Sankyo Co Ltd モルホリンおよびチオモルホリン誘導体
GB9522845D0 (en) 1995-11-08 1996-01-10 Smithkline Beecham Plc Novel compounds
JP3822680B2 (ja) 1996-08-30 2006-09-20 新日本製鐵株式会社 誘導加熱された接合部の冷却方法および冷却装置
US6380387B1 (en) 1999-12-06 2002-04-30 Hoffmann-La Roche Inc. 4-Pyrimidinyl-n-acyl-l phenylalanines
AU2001246916B2 (en) 2000-04-21 2004-10-07 Shionogi & Co., Ltd. Oxadiazole derivatives having anticancer effects
FR2822727A1 (fr) 2001-04-03 2002-10-04 Gesal Ind Procede d'application d'un revetement resistant aux hautes temperatures, dispositif pour la mise en oeuvre de ce procede et objet pourvu dudit revetement
JP3649223B2 (ja) 2003-01-08 2005-05-18 株式会社日立製作所 配管系の熱処理方法および熱処理装置
EP1631557B1 (en) 2003-06-12 2006-12-20 Btg International Limited Cyclic hydroxylamine as psychoactive compounds
EP1646788A1 (de) 2003-07-10 2006-04-19 Robert Bosch Gmbh Kolbenmaschine
CA2539033C (en) 2003-09-12 2013-03-05 Neuronova Ab Treatment of disease or injury of the nervous system with fty720
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
GB0329498D0 (en) 2003-12-19 2004-01-28 Novartis Ag Organic compounds
EP1716148A2 (en) 2003-12-23 2006-11-02 Arena Pharmaceuticals, Inc. Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
GB0401332D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
JP4185154B2 (ja) 2004-04-30 2008-11-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 中枢神経系障害治療用の置換モルホリン化合物
GB0409744D0 (en) 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
EP1804793A4 (en) 2004-10-22 2010-03-31 Merck Sharp & Dohme 2- (ARYL) AZACYCLYLMETHYL-CARBOXYLATE, SULPHONATE, PHOSPHONATE, PHOSPHINATE AND HETEROCYCLES AS S1P RECEPTOR AGONISTS
JP4491334B2 (ja) 2004-12-01 2010-06-30 日立Ｇｅニュークリア・エナジー株式会社 配管の熱処理方法および装置
JP4599250B2 (ja) 2005-08-10 2010-12-15 株式会社東芝 高周波誘導加熱時外面温度制御方法および当該制御装置
JP2007063642A (ja) 2005-09-01 2007-03-15 Hitachi Ltd 残留応力改善方法と高周波誘導加熱用コイル
WO2007057775A1 (en) 2005-11-21 2007-05-24 Pfizer Limited Spiropiperidine derivatives
ES2338716T3 (es) 2006-01-27 2010-05-11 F.Hoffmann-La Roche Ag Uso de derivados de 4-imidazol para trastornos del snc.
KR20080080410A (ko) 2006-01-27 2008-09-03 에프. 호프만-라 로슈 아게 이미다졸린 유도체의 치환된 2-이미다졸의 용도
AU2007221021B2 (en) 2006-02-28 2013-01-17 Dart Neuroscience (Cayman) Ltd Therapeutic piperazines as PDE4 inhibitors
EP2049548A1 (en) 2006-07-27 2009-04-22 UCB Pharma, S.A. Fused oxazoles & thiazoles as histamine h3- receptor ligands
WO2008028937A1 (en) 2006-09-08 2008-03-13 Novartis Ag N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
CA2672727A1 (en) 2006-12-21 2008-07-03 Abbott Laboratories Sphingosine-1-phosphate receptor agonist and antagonist compounds
WO2008096746A1 (ja) 2007-02-06 2008-08-14 Takeda Pharmaceutical Company Limited スピロ化合物およびその用途
EP2121648A2 (en) 2007-03-21 2009-11-25 EPIX Pharmaceuticals, Inc. S1p receptor modulating compounds and use thereof
AU2008240679A1 (en) 2007-04-23 2008-10-30 Novartis Ag Phthalazine and isoquinoline derivatives with SLP receptor modulating activities
WO2009084501A1 (ja) 2007-12-27 2009-07-09 Asahi Kasei Pharma Corporation スルタム誘導体
JP2011510044A (ja) 2008-01-24 2011-03-31 ユセベ ファルマ ソシエテ アノニム シクロブトキシ基を含む化合物
EA018537B1 (ru) 2008-01-30 2013-08-30 Сефалон, Инк. Замещенные спироциклические производные пиперидина как лиганды гистамин-3 (h) рецептора
MX2010008375A (es) 2008-01-30 2011-03-04 Cephalon Inc Star Derivados de piperidina espirocíclicos substituidos como ligandos de receptores de histamina-3 (h3).
US20090321144A1 (en) 2008-06-30 2009-12-31 Wyble Kevin J Protecting an element from excessive surface wear by localized hardening
AR077969A1 (es) 2009-08-31 2011-10-05 Abbott Healthcare Products Bv Derivados de (tio)morfolina comomoduladores de s1p
PT2531177T (pt) 2010-02-04 2016-08-17 Esteve Labor Dr Polimorfos e solvatos de cloridrato de 4-[-2-[[5-metil-1-(2-naftalenil)-1h-pirazol-3-il]oxi]etil]morfolina
CN101812058B (zh) 2010-04-13 2012-03-21 湖南大学 吲哚美辛2-芳基吗啉乙酯及其制备方法与应用
TWI522361B (zh) * 2010-07-09 2016-02-21 艾伯維公司 作為s1p調節劑的稠合雜環衍生物
TWI543984B (zh) 2010-07-09 2016-08-01 艾伯維公司 作為s1p調節劑的螺-哌啶衍生物
TW201206893A (en) 2010-07-09 2012-02-16 Abbott Healthcare Products Bv Bisaryl (thio) morpholine derivatives as S1P modulators
BR112016021699B1 (pt) 2014-03-21 2023-01-24 Iogen Energy Corporation Método para processar uma matéria-prima celulósica em alta consistência
CN114650996A (zh) 2019-10-31 2022-06-21 逃逸生物有限公司 用于制备s1p受体调节剂的方法

Also Published As

Publication number Publication date
US11535632B2 (en) 2022-12-27
CN114728982A (zh) 2022-07-08
JP2022553802A (ja) 2022-12-26
TW202132311A (zh) 2021-09-01
BR112022008113A2 (pt) 2022-07-19
AU2020373047A1 (en) 2022-05-19
US20230339967A1 (en) 2023-10-26
KR20220123634A (ko) 2022-09-08
US20210139502A1 (en) 2021-05-13
CA3159378A1 (en) 2021-05-06
IL292547A (en) 2022-06-01
EP4051683A1 (en) 2022-09-07
WO2021087299A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
PH12020551062A1 (en) 1,2,4-oxadiazole compounds as inhibitors of cd47 signalling pathways
MX2022002877A (es) Antagonistas de cinasa progenitora hematopoyetica 1 (hpk1) y sus usos.
GEP20217248B (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
MX2021013197A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
GEP20207147B (en) Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
MX2021013193A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
AU2018272986A1 (en) Novel inhibitors of MAP4K1
WO2019090085A8 (en) Modulators of the integrated stress pathway
PH12016501600A1 (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
WO2020102646A3 (en) Inhibitors of arg1 and/or arg2
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
MY196186A (en) Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor
TN2017000134A1 (en) 2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors for treating alzheimer's disease
PH12017500841A1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
PH12020551352A1 (en) Arginase inhibitors
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
MY194468A (en) Oxy-fluoropiperidine derivatives as kinase inhhiitor
EA201990400A1 (ru) Соединения и композиции и их применение
ZA202207804B (en) Compounds and uses thereof
MX2020000523A (es) Compuestos de isocromano y usos de los mismos.
MX2022005084A (es) Formas sólidas de un modulador del receptor s1p a.
MX2022009308A (es) Compuestos y usos de estos.
MX2022009369A (es) Compuestos y usos de estos.
MX2020012900A (es) Potentes inhibidores de d-aminoacido oxidasa (daao) y sus usos.
PH12019500198A1 (en) Compounds and compositions and uses thereof